Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (381-390 of 551) with videos related to

Pageof 56
Sort By:
Elife|September 21, 2022
Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathwaysPan Cheng, Xin Zhao, Lizabeth Katsnelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumorsRobin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patientsVikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 1, 1994
[Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]M Paredes Espinoza, S M Lippman, J J Kavanagh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemopreventionD M Shin, X C Xu, S M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasiaS Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.
Cancer|February 24, 2012
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitorsWoo-Young Kim, Ludmila Prudkin, Lei Feng, et al.
Journal of the National Cancer Institute|October 5, 2013
Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathwayDong Hoon Shin, Hyo-Jong Lee, Hye-Young Min, et al.
Molecular Cancer Therapeutics|February 14, 2016
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT ExperienceMaria Schwaederle, Barbara A Parker, Richard B Schwab, et al.
Journal of the National Cancer Institute|April 17, 1996
p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinomaD M Shin, J S Lee, S M Lippman, et al.
Pageof 56

Showing results (381-390 of 551) with videos related to

Sort By:
Pageof 56
Elife|September 21, 2022
Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathwaysPan Cheng, Xin Zhao, Lizabeth Katsnelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumorsRobin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patientsVikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 1, 1994
[Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]M Paredes Espinoza, S M Lippman, J J Kavanagh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemopreventionD M Shin, X C Xu, S M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasiaS Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.
Cancer|February 24, 2012
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitorsWoo-Young Kim, Ludmila Prudkin, Lei Feng, et al.
Journal of the National Cancer Institute|October 5, 2013
Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathwayDong Hoon Shin, Hyo-Jong Lee, Hye-Young Min, et al.
Molecular Cancer Therapeutics|February 14, 2016
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT ExperienceMaria Schwaederle, Barbara A Parker, Richard B Schwab, et al.
Journal of the National Cancer Institute|April 17, 1996
p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinomaD M Shin, J S Lee, S M Lippman, et al.
Pageof 56